ArticleDermatology and therapy2026

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis.

Stephen Weidinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.